Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2P39

Crystal structure of human FGF23

Summary for 2P39
Entry DOI10.2210/pdb2p39/pdb
Related2P23
Related PRD IDPRD_900013
DescriptorFibroblast growth factor 23, 1,3,4,6-tetra-O-sulfo-beta-D-fructofuranose-(2-1)-2,3,4,6-tetra-O-sulfonato-alpha-D-glucopyranose (3 entities in total)
Functional Keywordsatypical beta-trefoil fold, signaling protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight18839.04
Authors
Mohammadi, M. (deposition date: 2007-03-08, release date: 2007-04-10, Last modification date: 2024-10-30)
Primary citationGoetz, R.,Beenken, A.,Ibrahimi, O.A.,Kalinina, J.,Olsen, S.K.,Eliseenkova, A.V.,Xu, C.,Neubert, T.A.,Zhang, F.,Linhardt, R.J.,Yu, X.,White, K.E.,Inagaki, T.,Kliewer, S.A.,Yamamoto, M.,Kurosu, H.,Ogawa, Y.,Kuro-O, M.,Lanske, B.,Razzaque, M.S.,Mohammadi, M.
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
Mol.Cell.Biol., 27:3417-3428, 2007
Cited by
PubMed Abstract: Unique among fibroblast growth factors (FGFs), FGF19, -21, and -23 act in an endocrine fashion to regulate energy, bile acid, glucose, lipid, phosphate, and vitamin D homeostasis. These FGFs require the presence of Klotho/betaKlotho in their target tissues. Here, we present the crystal structures of FGF19 alone and FGF23 in complex with sucrose octasulfate, a disaccharide chemically related to heparin. The conformation of the heparin-binding region between beta strands 10 and 12 in FGF19 and FGF23 diverges completely from the common conformation adopted by paracrine-acting FGFs. A cleft between this region and the beta1-beta2 loop, the other heparin-binding region, precludes direct interaction between heparin/heparan sulfate and backbone atoms of FGF19/23. This reduces the heparin-binding affinity of these ligands and confers endocrine function. Klotho/betaKlotho have evolved as a compensatory mechanism for the poor ability of heparin/heparan sulfate to promote binding of FGF19, -21, and -23 to their cognate receptors.
PubMed: 17339340
DOI: 10.1128/MCB.02249-06
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.5 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon